SPL Mapping FHIR Implementation Guide
0.1.0 - Build CI United States of America flag

SPL Mapping FHIR Implementation Guide, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-spl/ and changes regularly. See the Directory of published versions

Example Bundle: AllopurinolTabletLabelBundle

Generated Narrative: Composition

ResourceComposition "AllopurinolTabletLabelComposition"

Profile: ProductSubmissionDocument

VersionNumber: 1

identifier: Uniform Resource Identifier (URI)/urn:uuid:c9a01871-bbf8-4b31-9b9b-9fa8c0997b29

status: final

type: HUMAN PRESCRIPTION DRUG LABEL (LOINC#34391-3)

date: 2017-02-04

author: See on this page: Organization/AidarexPharmaceuticals

title: Allopurinol<br/>Tablets USP<br/>Revised: February 2015<br/>Rx only        <br/>

DESCRIPTION

CLINICAL PHARMACOLOGY

INDICATIONS AND USAGE

CONTRAINDICATIONS

WARNINGS

PRECAUTIONS

General

Information for Patients

Laboratory Tests

Drug Interactions

Drug/Laboratory Interactions

Pregnancy

Nursing Mothers

Pediatric Use

ADVERSE REACTIONS

Most Common Reactions*<br/>Probably Causally Related

Incidence Less Than 1%<br/>Probably Causally Related

Incidence Less Than 1%<br/>Causal Relationship Unknown

OVERDOSAGE

DOSAGE AND ADMINISTRATION

HOW SUPPLIED

SPL LISTING DATA ELEMENTS SECTION

PRINCIPAL DISPLAY PANEL